The_company,_with registered_office_located in CITY, LOCATION, is primarily_engaged in the research,_development, manufacture and distribution of Cardiac Thrombolytic Agents and DAT (CRIMINAL_CHARGE of Abuse Testing) reagents in LOCATION and abroad, through its_subsidiaries. The company is NUMBER of the leading_suppliers of Cardiac Thrombolytic Agents in the COUNTRY COUNTRY. In DATE DATE DATE_DATE, the company was_acquired_by the COUNTRY - based ORGANIZATION ORGANIZATION, which is NUMBER of the world_'s_leading research - focused healthcare groups in the fields of pharmaceuticals and diagnostics.